|
NEUP Neuphoria Therapeutics Inc 1191070 |
| Balance Sheet |
|
Current Assets
|
$21,657,908.00 |
|
Assets
|
$43,003,902.00 |
|
Current Liabilities
|
$1,513,309.00 |
|
Liabilities
|
$9,856,043.00 |
|
Equity
|
$29,423,944.00 |
|
Shares Out
|
5377329.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-13,566,928.00 |
|
Investing Cash Flow
|
$479,528.00 |
| Market Analysis |
Market Cap
|
$21,079,129.68 |
|
Price
|
$3.82 |
|
BVPS
|
5.47 |
|
PB
|
0.72 |
|
EPS
|
-0.09 |
|
PS
|
1.16 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:42 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:42 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NEUP documents filed with the SEC.
NEUP Filings
Clear
